GC Biopharma, a South Korean pharmaceutical company, announced that its U.S. subsidiary, ABO Holdings, has received FDA ...

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...

A major change in pediatric dental care may be coming soon as the Food and Drug Administration (FDA) announced today that it ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The Food and Drug Administration is working to remove ingestible fluoride tablets and prescription for children from the ...

Cytokinetics' PDUFA date for aficamten was extended to December 26th of 2025, due to the FDA's need to review a submitted ...

There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The U.S. Food and Drug Administration will remove pediatric ingestible fluoride products from the market. The agency cites ...

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

President Donald Trump’s push to lower pharmaceutical prices by buying more drugs from abroad likely won’t work and may not ...

Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...

Red dye No. 3 is now banned in the US -- but it'll take time to phase it out completely. In the meantime, the FDA just ...